Page last updated: 2024-08-24

aripiprazole and imidazolidines

aripiprazole has been researched along with imidazolidines in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bojarski, AJ; Bucki, A; Byrtus, H; Czopek, A; Kalinowska-Tłuścik, J; Kazek, G; Kołaczkowski, M; Partyka, A; Pawłowski, M; Piaskowska, A; Wesołowska, A	1

Other Studies

1 other study(ies) available for aripiprazole and imidazolidines

Article	Year
Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent. Bioorganic & medicinal chemistry, 2015, Jul-01, Volume: 23, Issue:13 Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Depression; Dextroamphetamine; Hydantoins; Hyperkinesis; Imidazolidines; Male; Mice; Piperazines; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Serotonin; Structure-Activity Relationship; Swimming	2015

Article

Year

Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent.

Bioorganic & medicinal chemistry, 2015, Jul-01, Volume: 23, Issue:13

Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Depression; Dextroamphetamine; Hydantoins; Hyperkinesis; Imidazolidines; Male; Mice; Piperazines; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Serotonin; Structure-Activity Relationship; Swimming

2015